or Try an Advanced Search...

    Technical Analysis for VRCA - Verrica Pharmaceuticals Inc.

    Grade Last Price % Change Price Change
    A 6.79 -2.72% -0.19
    VRCA closed down 2.72 percent on Monday, April 22, 2024, on 2.21 times normal volume.
    Earnings due: May 7
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical VRCA trend table...
    Date Alert Name Type % Chg
    MACD Bearish Signal Line Cross Bearish 0.00%
    Wide Bands Range Expansion 0.00%
    1,2,3 Pullback Bullish Bullish Swing Setup -2.72%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.72%
    Wide Bands Range Expansion -2.72%
    Overbought Stochastic Strength -2.72%
    Wide Bands Range Expansion -1.59%
    Overbought Stochastic Strength -1.59%
    Inside Day Range Contraction -3.82%
    Wide Bands Range Expansion -3.82%
    Older End-of-Day Signals for VRCA ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 20 hours ago
    Down 3% about 20 hours ago
    Fell Below Previous Day's Low about 20 hours ago
    Down 1 ATR about 20 hours ago
    60 Minute Opening Range Breakdown about 20 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    VRCA Chart by TradingView
    Basic chart:

    Profile

    Verrica is a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs. The company’s lead product candidate, VP-102, is currently being evaluated in two Phase 3 clinical trials for the treatment of molluscum and in a Phase 2 clinical trial for the treatment of common warts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical Medication Pharmaceutical Products Clinical Trial Skin Diseases Treatment Of Skin Diseases Common Warts

    Is VRCA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 3 Strong week for Verrica Pharmaceuticals (NASDAQ:VRCA) shareholders doesn't alleviate pain of three-year loss
    Apr 2 Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
    Mar 26 Verrica Pharma gains as FDA lists Ycanth in Orange Book
    Mar 26 Verrica Pharmaceuticals Announces that YCANTH™ Receives New Chemical Entity Status and Orange Book Listing from the FDA
    Mar 2 When Will Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Become Profitable?
    Mar 2 Verrica Pharmaceuticals Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line
    Mar 1 Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q4 2023 Earnings Call Transcript
    Feb 29 Verrica Pharmaceuticals Inc. (VRCA) Q4 2023 Earnings Call Transcript
    Feb 29 Verrica Pharmaceuticals Inc (VRCA) Reports Fourth Quarter and Full-Year 2023 Financial Results
    Feb 29 Verrica Pharmaceuticals GAAP EPS of -$0.53 beats by $0.03, revenue of $1.98M beats by $1.03M
    See more VRCA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.755
    52 Week Low 2.86
    Average Volume 140,661
    200-Day Moving Average 5.03
    50-Day Moving Average 5.72
    20-Day Moving Average 6.50
    10-Day Moving Average 6.98
    Average True Range 0.34
    RSI (14) 61.69
    ADX 41.0
    +DI 24.51
    -DI 13.50
    Chandelier Exit (Long, 3 ATRs) 6.28
    Chandelier Exit (Short, 3 ATRs) 5.81
    Upper Bollinger Bands 7.77
    Lower Bollinger Band 5.22
    Percent B (%b) 0.62
    BandWidth 39.22
    MACD Line 0.41
    MACD Signal Line 0.42
    MACD Histogram -0.0092
    Fundamentals Value
    Market Cap 285.62 Million
    Num Shares 42.1 Million
    EPS -1.08
    Price-to-Earnings (P/E) Ratio -6.29
    Price-to-Sales 72.34
    Price-to-Book 5.47
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 7.44
    Resistance 3 (R3) 7.43 7.22 7.33
    Resistance 2 (R2) 7.22 7.05 7.22 7.29
    Resistance 1 (R1) 7.00 6.95 6.90 7.01 7.26
    Pivot Point 6.79 6.79 6.73 6.79 6.79
    Support 1 (S1) 6.57 6.62 6.47 6.58 6.32
    Support 2 (S2) 6.36 6.52 6.36 6.29
    Support 3 (S3) 6.14 6.36 6.25
    Support 4 (S4) 6.15